> 首页 > 产品 > 一抗 > 其他 > Anti-RSV-F Reference Antibody (clesrovimab）

Anti-RSV-F Reference Antibody (clesrovimab）

Anti-RSV-F Reference Antibody (clesrovimab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-RSV-F Reference Antibody (clesrovimab） is 100%, determined by SEC-HPLC.
Immobilized Human RSV (A2) Post-fusion glycoprotein F/ RSV post-F Protein (His Tag) at 2 µg/mL can bind clesrovimab, EC50= 0.02360 µg/mL.

产品详情
实验流程

Product Information
Application Applications Legend: E=ELISA WB=Western Blotting IHC=Immunohistochemistry IHC-P=Immunohistochemistry (Paraffin) IP=Immunoprecipitation IF=Immunofluorescence IC=Immunochemistry ICC=Immunocytochemistry FC=Flow Cytometry DB=Dot Blot	Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession	P13604
Reactivity	Human
Clonality	Monoclonal
Isotype	IgG1
Calculated MW	43274 Da

Additional Information
Target/Specificity	RSV-F
Expression system	CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.